
Biocept BIOC
Quarterly report 2023-Q2
added 08-14-2023
Biocept Shares 2011-2025 | BIOC
Annual Shares Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 M | 14.8 M | 11.8 M | 2.07 M | 280 K | 90.8 K | 31.9 K | 18.4 K | 4.44 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17 M | 4.44 K | 5.12 M |
Quarterly Shares Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 M | 17.6 M | 569 K | 17 M | 564 K | 16.8 M | 16.8 M | 15.4 M | 13.5 M | 13.4 M | 13.4 M | 13.3 M | 12.7 M | 7.9 M | 29.1 M | 2.3 M | 20.5 M | 9.79 M | 4.21 M | 2.77 M | 2.28 M | 1.91 M | 1.06 M | 995 K | 901 K | 707 K | 15.6 M | 8.37 M | 7.7 M | 6.57 M | 6.31 M | 6.24 M | 6.01 M | 3.46 M | 4.45 M | 4.45 M | 4.45 M | 2.62 M | 182 K | 182 K | 182 K | 181 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 29.1 M | 181 K | 7.47 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
31.2 M | $ 19.2 | 1.19 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 20.99 | 1.77 % | $ 226 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.17 | -6.81 % | $ 4.99 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 39.2 | -0.28 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
731 M | $ 230.16 | -0.24 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
28.4 M | $ 11.04 | 3.13 % | $ 313 M | ||
|
BioNano Genomics
BNGO
|
1.27 M | $ 1.54 | 2.33 % | $ 1.96 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
185 M | $ 101.87 | -0.03 % | $ 18.9 B | ||
|
DexCom
DXCM
|
386 M | $ 66.7 | -0.54 % | $ 25.7 B | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 26.34 | -0.57 % | $ 796 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
53.8 M | $ 18.92 | -0.79 % | $ 1.02 B | ||
|
Celcuity
CELC
|
39.4 M | $ 99.52 | -0.4 % | $ 3.93 B | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
31.9 K | $ 3.16 | 1.28 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
181 M | $ 226.65 | -0.44 % | $ 41.1 B | ||
|
Guardant Health
GH
|
123 M | $ 102.32 | 1.71 % | $ 12.6 B | ||
|
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | ||
|
NeoGenomics
NEO
|
127 M | $ 12.03 | -1.64 % | $ 1.52 B | ||
|
Myriad Genetics
MYGN
|
90.6 M | $ 6.15 | -0.32 % | $ 557 M | ||
|
ENDRA Life Sciences
NDRA
|
537 K | $ 4.56 | -4.2 % | $ 2.45 M | ||
|
Neogen Corporation
NEOG
|
217 M | $ 7.04 | -0.21 % | $ 1.53 B | ||
|
Quidel Corporation
QDEL
|
42.1 M | $ 28.76 | -1.84 % | $ 1.21 B | ||
|
National Research Corporation
NRC
|
24.5 M | $ 18.64 | -0.08 % | $ 457 M | ||
|
Illumina
ILMN
|
159 M | $ 131.31 | -1.09 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
51.4 M | $ 200.78 | -0.59 % | $ 10.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
904 M | $ 27.17 | -0.8 % | $ 20 B | ||
|
Personalis
PSNL
|
59.3 M | $ 8.04 | 0.88 % | $ 476 M | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 174.56 | -0.53 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
130 M | $ 6.78 | 0.86 % | $ 879 M | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
RadNet
RDNT
|
73 M | $ 71.5 | 0.01 % | $ 5.22 B | ||
|
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 252.03 | -0.41 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 182.5 | -0.27 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
82.5 M | $ 680.35 | -0.29 % | $ 56.1 B | ||
|
Lantheus Holdings
LNTH
|
69.2 M | $ 66.96 | -0.3 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
21.2 M | $ 1 402.54 | -0.88 % | $ 29.8 B |